Established in May 2024, YIJI Biology focuses on the development of companion animal disease models, with a particular emphasis on feline models, and provides comprehensive CRO services. As one of the first companies in China dedicated to feline disease model research, we are committed to delivering high-quality and precise experimental solutions for pharmaceutical companies, research institutions, and academic organizations. Through a strategic partnership with the Shanghai Veterinary Research Institute of the Chinese Academy of Agricultural Sciences, we have built a cutting-edge platform for feline model development, offering end-to-end services from model creation and experimental design to data analysis.
Our Mission
At YIJI Biology, we are driven by a mission to foster innovation and scientific advancement in the companion animal health sector. We believe that the health of companion animals is intrinsically linked to human well-being, and we are dedicated to advancing the global pet health industry through pioneering research and technical excellence.
Our Advantages
Industry-Leading Expertise
Our R&D team comprises seasoned experts who have successfully developed China’s first feline trivalent vaccine, bringing extensive experience and unparalleled expertise in disease model development.
Strategic Collaborations
We work closely with the Shanghai Veterinary Research Institute of the Chinese Academy of Agricultural Sciences, leveraging access to comprehensive virus and parasite libraries. Our certifications include CNAS, CMA, and GCP, ensuring compliance with international research standards.
Advanced Research Facilities
Our state-of-the-art 3,000 m² negative-pressure cat breeding facility is equipped with cutting-edge ventilation systems, enabling the breeding of genetically modified and rare animal models under optimal conditions.
Comprehensive CRO Services
From vaccine and drug regulatory submissions to experimental design and data analysis, we provide fully integrated CRO solutions, accelerating the research and development timelines of our clients.